跳至主要内容
临床试验/NL-OMON50854
NL-OMON50854尚未招募不适用

Patient Reported Outcomes while Manipulating the Immune System in autoimmune Encephalitis - The PROMISE study

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 400 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
16 至 64(—)

入选标准

  • 1. Adults or adolescents from the age of 16 years;
  • 2. Sufficiently fluent in Dutch;
  • 3. Have a clinical high suspicion of an autoimmune encephalitis or a
  • paraneoplastic neurological syndrome
  • 4. Antibodies are detected in serum and/or CSF with cell-based assay and
  • affirmed with immunohistochemistry

排除标准

  • 1. Impossible to assess outcome related to autoimmune encephalitis due to
  • pre-existing comorbidities, objectified as a premorbid mRS over two.
  • 2. The patient and/or legal representative is withholding informed consent;
  • 3. The patient withdraws, after initial consent.

研究者

相似试验